Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (1): 31-36.DOI: 10.3969/j.issn.1673-8640.2018.01.006
• Orginal Article • Previous Articles Next Articles
CHEN Shuimian, YU Chongzhao, LI Enling, ZHU Haoming, LU Jingbo, ZHENG Bing
Received:2017-03-12
Online:2018-01-30
Published:2021-03-18
CLC Number:
CHEN Shuimian, YU Chongzhao, LI Enling, ZHU Haoming, LU Jingbo, ZHENG Bing. Autoantibody-related parameters in patients with autoimmune diseases and healthy subjects[J]. Laboratory Medicine, 2018, 33(1): 31-36.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.01.006
| 组别 | 例数 | ANA核型 | ANA阴性 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 均质型 | 核颗粒型 | 混合型 | 胞浆颗粒型 | 着丝点型 | 核仁型 | 其他型 | |||
| SLE组 | 1 001 | 446(44.6) | 396(39.6) | 70(7.0) | 18(1.8) | 20(2.0) | 5(0.5) | 6(0.6) | 40(4.0) |
| RA组 | 408 | 201(49.3) | 55(13.5) | 11(2.7) | 10(2.5) | 7(1.7) | 7(1.7) | 4(1.0) | 113(27.7) |
| SS组 | 255 | 49(19.2) | 138(54.1) | 19(7.5) | 6(2.4) | 20(7.8) | 2(0.8) | 2(0.8) | 19(7.5) |
| IM组 | 54 | 7(13.0) | 10(18.5) | 11(20.4) | 5(9.3) | 0(0.0) | 4(7.4) | 1(1.9) | 16(29.6) |
| PSS组 | 40 | 9(22.5) | 7(17.5) | 5(12.5) | 2(5.0) | 7(17.5) | 3(7.5) | 1(2.5) | 6(15.0) |
| AS组 | 36 | 7(19.4) | 2(5.6) | 0(0.0) | 0(0.0) | 0(0.0) | 1(2.8) | 0(0.0) | 26(72.2) |
| MCTD组 | 17 | 1(5.9) | 15(88.2) | 0(0.0) | 0(0.0) | 1(5.9) | 0(0.0) | 0(0.0) | 0(0.0) |
| PBC组 | 57 | 0(0.0) | 4(7.0) | 29(50.9) | 20(35.1) | 1(1.8) | 0(0.0) | 2(3.5) | 1(1.8) |
| AIH组 | 37 | 0(0.0) | 0(0.0) | 23(62.2) | 7(18.9) | 3(8.1) | 0(0.0) | 4(10.8) | 0(0.0) |
| 合计 | 1 905 | 720(37.8) | 627(32.9) | 168(8.8) | 68(3.6) | 59(3.1) | 22(1.2) | 20(1.0) | 221(11.6) |
| 组别 | 例数 | ANA核型 | ANA阴性 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 均质型 | 核颗粒型 | 混合型 | 胞浆颗粒型 | 着丝点型 | 核仁型 | 其他型 | |||
| SLE组 | 1 001 | 446(44.6) | 396(39.6) | 70(7.0) | 18(1.8) | 20(2.0) | 5(0.5) | 6(0.6) | 40(4.0) |
| RA组 | 408 | 201(49.3) | 55(13.5) | 11(2.7) | 10(2.5) | 7(1.7) | 7(1.7) | 4(1.0) | 113(27.7) |
| SS组 | 255 | 49(19.2) | 138(54.1) | 19(7.5) | 6(2.4) | 20(7.8) | 2(0.8) | 2(0.8) | 19(7.5) |
| IM组 | 54 | 7(13.0) | 10(18.5) | 11(20.4) | 5(9.3) | 0(0.0) | 4(7.4) | 1(1.9) | 16(29.6) |
| PSS组 | 40 | 9(22.5) | 7(17.5) | 5(12.5) | 2(5.0) | 7(17.5) | 3(7.5) | 1(2.5) | 6(15.0) |
| AS组 | 36 | 7(19.4) | 2(5.6) | 0(0.0) | 0(0.0) | 0(0.0) | 1(2.8) | 0(0.0) | 26(72.2) |
| MCTD组 | 17 | 1(5.9) | 15(88.2) | 0(0.0) | 0(0.0) | 1(5.9) | 0(0.0) | 0(0.0) | 0(0.0) |
| PBC组 | 57 | 0(0.0) | 4(7.0) | 29(50.9) | 20(35.1) | 1(1.8) | 0(0.0) | 2(3.5) | 1(1.8) |
| AIH组 | 37 | 0(0.0) | 0(0.0) | 23(62.2) | 7(18.9) | 3(8.1) | 0(0.0) | 4(10.8) | 0(0.0) |
| 合计 | 1 905 | 720(37.8) | 627(32.9) | 168(8.8) | 68(3.6) | 59(3.1) | 22(1.2) | 20(1.0) | 221(11.6) |
| 组别 | 例数 | ENA谱 | 抗 ds-DNA抗体 | 抗Nuc抗体 | ANA | ENA | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 抗Sm 抗体 | 抗U1RNP抗体 | 抗SSA-Ro60抗体 | 抗SSB抗体 | 抗Scl-70抗体 | 抗Jo-1 抗体 | 抗Rib-p抗体 | ||||||
| SLE组 | 1 001 | 78 (96.3) | 302 (87.0) | 505 (68.2) | 113 (57.9) | 4 (40.0) | 2 (18.2) | 78 (91.8) | 453 (91.0) | 303(91.8) | 961(60.4) | 657 (71.0) |
| RA组 | 408 | 1 (1.2) | 4 (1.2) | 40 (5.4) | 4 (2.1) | 0 (0.0) | 3 (27.3) | 2 (2.4) | 14 (2.8) | 9 (2.7) | 295 (18.5) | 46 (5.0) |
| SS组 | 255 | 1 (1.2) | 19 (5.5) | 177 (23.9) | 73 (37.4) | 0 (0.0) | 0 (0.0) | 5 (5.9) | 26 (5.2) | 11 (3.3) | 236 (14.8) | 182 (19.7) |
| AS组 | 3 | 0 (0.0) | 0 (0.0) | 1 (0.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 10 (0.6) | 1 (0.1) |
| MCTD组 | 17 | 1 (1.2) | 16 (4.6) | 6 (0.8) | 1 (0.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.4) | 5 (1.5) | 17 (1.1) | 16 (1.7) |
| IM组 | 54 | 0 (0.0) | 2 (0.6) | 8 (1.1) | 2 (1.0) | 0 (0.0) | 6 (54.5) | 0 (0.0) | 0 (0.0) | 1 (0.3) | 38 (2.4) | 8 (0.9) |
| PSS组 | 54 | 0 (0.0) | 4 (1.2) | 3 (0.4) | 2 (1.0) | 6 (60.0) | 0 (0.0) | 0 (0.0) | 3 (0.6) | 1 (0.3) | 34 (2.1) | 11 (1.2) |
| 合计 | 1 811 | 81 (4.5) | 347 (19.2) | 740 (40.9) | 195 (10.8) | 10 (0.6) | 11 (0.6) | 85 (4.7) | 498 (27.5) | 330(18.2) | 1 591 (87.9) | 926 (51.1) |
| 组别 | 例数 | ENA谱 | 抗 ds-DNA抗体 | 抗Nuc抗体 | ANA | ENA | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 抗Sm 抗体 | 抗U1RNP抗体 | 抗SSA-Ro60抗体 | 抗SSB抗体 | 抗Scl-70抗体 | 抗Jo-1 抗体 | 抗Rib-p抗体 | ||||||
| SLE组 | 1 001 | 78 (96.3) | 302 (87.0) | 505 (68.2) | 113 (57.9) | 4 (40.0) | 2 (18.2) | 78 (91.8) | 453 (91.0) | 303(91.8) | 961(60.4) | 657 (71.0) |
| RA组 | 408 | 1 (1.2) | 4 (1.2) | 40 (5.4) | 4 (2.1) | 0 (0.0) | 3 (27.3) | 2 (2.4) | 14 (2.8) | 9 (2.7) | 295 (18.5) | 46 (5.0) |
| SS组 | 255 | 1 (1.2) | 19 (5.5) | 177 (23.9) | 73 (37.4) | 0 (0.0) | 0 (0.0) | 5 (5.9) | 26 (5.2) | 11 (3.3) | 236 (14.8) | 182 (19.7) |
| AS组 | 3 | 0 (0.0) | 0 (0.0) | 1 (0.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 10 (0.6) | 1 (0.1) |
| MCTD组 | 17 | 1 (1.2) | 16 (4.6) | 6 (0.8) | 1 (0.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.4) | 5 (1.5) | 17 (1.1) | 16 (1.7) |
| IM组 | 54 | 0 (0.0) | 2 (0.6) | 8 (1.1) | 2 (1.0) | 0 (0.0) | 6 (54.5) | 0 (0.0) | 0 (0.0) | 1 (0.3) | 38 (2.4) | 8 (0.9) |
| PSS组 | 54 | 0 (0.0) | 4 (1.2) | 3 (0.4) | 2 (1.0) | 6 (60.0) | 0 (0.0) | 0 (0.0) | 3 (0.6) | 1 (0.3) | 34 (2.1) | 11 (1.2) |
| 合计 | 1 811 | 81 (4.5) | 347 (19.2) | 740 (40.9) | 195 (10.8) | 10 (0.6) | 11 (0.6) | 85 (4.7) | 498 (27.5) | 330(18.2) | 1 591 (87.9) | 926 (51.1) |
| SLE 患者 | 例数 | 一般情况 | ENA谱 | 抗 ds-DNA抗体 | 抗Nuc 抗体 | ANA | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 性别(女) | 年龄 (岁) | 抗Sm 抗体 | 抗U1RNP抗体 | 抗SSA-Ro60抗体 | 抗SSB 抗体 | 抗Scl-70抗体 | 抗Jo-1抗体 | 抗Rib-p抗体 | |||||
| 成人组 | 898 | 833 (92.8) | 38.2± 13.7 | 66(7.3) | 283 (31.5) | 460 (51.2) | 101 (11.2) | 4 (0.5) | 1 (0.1) | 69 (7.7) | 422 (47.0) | 289 (32.2) | 867 (96.5) |
| 小儿组 | 103 | 80(77.7) | 13.0± 2.9 | 12 (11.7) | 19 (18.5) | 44 (42.7) | 12 (11.7) | 0 (0.0) | 1 (1.7) | 9 (8.7) | 31 (30.1) | 14 (13.6) | 94 (91.3) |
| P值 | 0.00 | 0.12 | 0.01 | 0.10 | 0.90 | 0.06 | 0.71 | 0.00 | 0.00 | 0.01 | |||
| SLE 患者 | 例数 | 一般情况 | ENA谱 | 抗 ds-DNA抗体 | 抗Nuc 抗体 | ANA | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 性别(女) | 年龄 (岁) | 抗Sm 抗体 | 抗U1RNP抗体 | 抗SSA-Ro60抗体 | 抗SSB 抗体 | 抗Scl-70抗体 | 抗Jo-1抗体 | 抗Rib-p抗体 | |||||
| 成人组 | 898 | 833 (92.8) | 38.2± 13.7 | 66(7.3) | 283 (31.5) | 460 (51.2) | 101 (11.2) | 4 (0.5) | 1 (0.1) | 69 (7.7) | 422 (47.0) | 289 (32.2) | 867 (96.5) |
| 小儿组 | 103 | 80(77.7) | 13.0± 2.9 | 12 (11.7) | 19 (18.5) | 44 (42.7) | 12 (11.7) | 0 (0.0) | 1 (1.7) | 9 (8.7) | 31 (30.1) | 14 (13.6) | 94 (91.3) |
| P值 | 0.00 | 0.12 | 0.01 | 0.10 | 0.90 | 0.06 | 0.71 | 0.00 | 0.00 | 0.01 | |||
| [1] | ZAFRIR Y,GILBURD B,CARRASCO M G,et al.Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases[J]. Immunol Res,2013,56(2-3):451-456. |
| [2] | ALMOGREN A,SHAKOOR Z,HASANATO R M,et al.Autoantibody detection:prevailing practices at a tertiary care hospital in Riyadh[J]. Clin Lab,2014,60(4):671-675. |
| [3] | AVOUAC J,GOSSEC L,DOUGADOS M.Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis:a systematic literature review[J]. Ann Rheum Dis,2006,65(7):845-851. |
| [4] | 周仁芳,胡朝军,张蜀澜,等. 临床标本抗核抗体102 651例检测结果回顾性分析[J]. 中华检验医学杂志,2009,32(12):1339-1343. |
| [5] | 詹文丽,李立新,黄卓春,等. 2种检测系统测定抗核抗体谱的一致性分析[J]. 检验医学,2016,31(11):969-973. |
| [6] | 黄静芳,徐红星. 系统性红斑狼疮患者抗核抗体检测结果分析[J]. 检验医学,2012,27(11):975-976. |
| [7] | 李正,陈杰,袁文娟,等. 抗核抗体核型分布及核型与特异性抗体相关性分析[J]. 标记免疫分析与临床,2013,20(6):433-435. |
| [8] | ZHOU Y,TAN L,QUE Q,et al.Study of association between HLA-DR4 and DR53 and autoantibody detection in rheumatoid arthritis[J]. J Immunoassay Immunochem,2013,34(2):126-133. |
| [9] | 李晔,刘兵兵,刘旭,等. ANA和自身免疫性肝病相关抗体检测在自身免疫性肝病诊断中的价值[J].中外医学研究,2013,11(34):64-66. |
| [10] | YOUNG B J,MALLYA R K,LESLIE R D,et al.Anti-keratin antibodies in rheumatoid arthritis[J] . Br Med J,1979,2(6182):97-99. |
| [11] | PANZA F,ALCARO M C, PETRELLI F,et al.A novel DNA/histone H4 peptide complex detects autoantibodies in systemic lupus erythematosus sera[J].Arthritis Res Ther,2016,18(1):220. |
| [12] | 尧雨根. 儿童与成人系统性红斑狼疮的临床特点比较[J]. 海南医学,2012,23(22):84-85. |
| [13] | 钱培新,王蕾. 健康体检人群中抗核抗体的年龄及性别分布状况研究[J]. 海南医学,2015,26(2):201-202. |
| [14] | 曾东良,姜焕好. 自身抗体检测作为体检体检项目的预警价值[J]. 检验医学与临床,2014,11(9):1262-1263. |
| [1] | AN Yinghong, YAO Kechun, SU Chengming, TANG Jinhua, YANG Lixin, GAO Jie, XU Yanting, YAN Qiuhong, ZHAN Hongyan, MA Yueyun. Survey of serum homocysteine levels of apparently healthy subjects in Beijing [J]. Laboratory Medicine, 2023, 38(11): 1036-1040. |
| [2] | YANG Keke, WU Junyuan, CAO Xingjian. Role of anti-nuclear antibody-dense fine speckled pattern for diagnosing systemic autoimmune rheumatic disease [J]. Laboratory Medicine, 2021, 36(7): 691-695. |
| [3] | LUO Ting, PAN Xiujun. Research progress on neutrophil extracellular traps in ulcerative colitis [J]. Laboratory Medicine, 2020, 35(6): 626-630. |
| [4] | ZHANG Han, ZHANG Chaoyan, XIE Qiuxia, TIAN Jianhui. Analysis on the results of Epstein-Barr virus antibody combined determination in healthy subjects of Beijing [J]. Laboratory Medicine, 2020, 35(3): 247-250. |
| [5] | ZHANG Sujie, JU Yi, LI Qing, SUN Hewei, FENG Xueqing, JIN Zhonggan, LI Shuijun, LI Yujie, LI Jinrong. Analysis of serum 25-hydroxyvitamin D levels in healthy subjects [J]. Laboratory Medicine, 2020, 35(10): 1028-1031. |
| [6] | LUO Wenbin, WANG Yekai, YU Qian, LIN Qilong. Cluster analysis of serum anti-nuclear antibody profile in 164 subjects with nuclear speckled pattern [J]. Laboratory Medicine, 2018, 33(7): 604-607. |
| [7] | ZHANG Minjie, GAO Yufang. Relationship between the levels of anti-nuclear antibodies and Epstein-Barr virus antibodies [J]. Laboratory Medicine, 2018, 33(5): 416-420. |
| [8] | SHU Jie, SHENG Huiming. Research progress in laboratory diagnosis of IgG4-related diseases [J]. Laboratory Medicine, 2018, 33(11): 1043-1048. |
| [9] | TAN Liming, DING Yaodong, CHEN Juanjuan, LI Hua, JIANG Yongqing, WAN Yani, WANG Liyun, WANG Tian. Complement 1q determination for autoimmune diseases [J]. Laboratory Medicine, 2017, 32(8): 686-690. |
| [10] | ZHOU Xinyun, CHEN Hui, SHEN Lisong. Research progress on the new types of autoantibodies in autoimmune diseases [J]. Laboratory Medicine, 2017, 32(6): 543-548. |
| [11] | ZHOU Xinyun, CHEN Hui, SHEN Lisong. Research progress on the new types of autoantibodies in autoimmune diseases [J]. Laboratory Medicine, 2017, 32(6): 543-548. |
| [12] | JIA Rulin, LI Yun, ZHAO Jing, ZHU Lei, YANG Dongyue, HE Jing, LI Zhanguo. EUROPattern auto-reading system for the determination of anti-nuclear antibody [J]. Laboratory Medicine, 2017, 32(12): 1143-1147. |
| [13] | MA Hongxia, ZHOU Yunheng, MA Liang, SHEN Jianfeng, LI Yang. Comparison of main biochemical indicators between healthy subjects and sub-healthy subjects with different sex [J]. Laboratory Medicine, 2016, 31(12): 1011-1016. |
| [14] | LI Shengjie, ZHANG Aiping, CAO Wenjun. Complement deficiency and its associated diseases [J]. Laboratory Medicine, 2015, 30(2): 195-200. |
| [15] | HU Xiaobin,LU Xinmin,YU Xiao, XIANG Xiaojie. Investigation of the reference intervals of serum cardiac marker in healthy subjects [J]. , 2013, 28(7): 573-576. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||